Episode Details

AbbVie: A Reliable Choice for Dividend Investors

AbbVie, a pharmaceutical giant spun off from Abbott Laboratories in 2013, offers a dividend yield of 3.38%, significantly higher than the S&P 500 average of 1.1%. With a consistent track record of dividend growth, AbbVie has increased payouts by over 330% since the spin-off, providing a reliable income stream. The companys stock has delivered average annual gains of 16.2% over the past decade, with a forward price-to-earnings ratio of 14, making it a reasonable choice for potential growth.

Support the show:
Get a discount at https://solipillow.com/discount/dnn.

Advertise on DNN:
advertise@thednn.ai

This is an automated, high-level news summary based on public reporting.
Report issues to feedback@thednn.ai.

View sources & latest updates:
https://sources.thednn.ai/00778c958b7ad92b